Ability of routine blood tests (RBTs) in asymptomatic patients (pts) with indolent non-Hodgkin lymphoma (iNHL) to detect relapse or clinically significant disease progression.

Conference Proceedings

Oliver Piercey, Zoe Loh, Joanna Chan, Geoffrey Chong, Andrew Grigg, Steven Cheema, Tania Cushion, Gurjot Gill, Matthew Whybird, Eliza Anne Hawkes

JOURNAL OF CLINICAL ONCOLOGY | AMER SOC CLINICAL ONCOLOGY | Published : 2019